13F

BCLI BRAINSTORM CELL THERAPEUTICS

2025Q3 · CUSIP 10501E300 · Sector: Healthcare & Biotech

No recent data · Not filed this quarter
Holders
5
Δ holders QoQ
-30
Breadth percentile
n/a
Whale holders
2
Δ whales
-11
Inst. holding value
$2K
New positions
0
Closed positions
30
Price momentum (1Q)
Put / Call
0/0

Breadth history (34 quarters)

2024Q4: Δ+28 · h=31 2025Q1: Δ+2 · h=33 2025Q2: Δ+2 · h=35 2025Q3: Δ-30 · h=5 2024Q4: holders=31 2025Q1: holders=33 2025Q2: holders=35 2025Q3: holders=5 -30 -15 +0 +15 +30 42137 24Q425Q125Q225Q3 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 1 lit events

Period Percentile Next-1Q return Next-2Q return
2024Q4 Top 19%

Options Sentiment

Put holders
0
QoQ: 0
Call holders
0
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
EPS (TTM)
$-0.85
EPS YoY
Revenue (TTM)
Revenue YoY
Quarterly Revenue & EPS (4Y)
2023-09-30: EPS -0.45 2023-12-31: EPS -5.28 2024-03-31: EPS -0.75 2024-06-30: EPS -0.60 2024-09-30: EPS -0.51 2024-12-31: EPS -0.45 2025-03-31: EPS -0.45 2025-06-30: EPS -0.34 2025-09-30: EPS -0.19 2025-12-31: EPS -0.13 2026-03-31: EPS -0.19 -5.81 -2.90 0.00 20222023202420252026 EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)